CellSource Co

CellSource Co FCF per Share

The Free Cash Flow per Share of CellSource Co (4880.T) as of Oct 27, 2026 is 14.63 JPY. In the previous year, Free Cash Flow per Share was 4.97 JPY — a change of 194.21% (higher).

FCF per Share

14.63JPY

YoY

194.21%

Last updated:

Free Cash Flow per Share of CellSource Co is 2025 14.63 JPY. Free Cash Flow per Share of CellSource Co was 2024 4.97 JPY. It decreases by 194.21% higher compared to the previous year.

The CellSource Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
9.50 JPY
Jan 1, 2019
8.40 JPY
Jan 1, 2020
15.66 JPY
Jan 1, 2021
43.89 JPY
Jan 1, 2022
39.18 JPY
Jan 1, 2023
25.70 JPY
Jan 1, 2024
4.97 JPY
Jan 1, 2025
14.63 JPY
The CellSource Co FCF per Share history
YEARFCF per ShareYoY
14.63JPY+194.21%
4.97JPY-80.66%
25.70JPY-34.40%
39.18JPY-10.72%
43.89JPY+180.28%
15.66JPY+86.34%
8.40JPY-11.57%
9.50JPY+85.25%
5.13JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Free Cash Flow per Share of CellSource Co is 14.63 JPY in 2025.

Free Cash Flow per Share of CellSource Co changed from 4.97 JPY to 14.63 JPY, representing a 194.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share CellSource Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — CellSource Co

All Key Metrics — CellSource Co